CORRECTED: Sacklers Saw Litigation Threat As Early As 2007, Creditors Say

Law360 (December 21, 2020, 11:15 PM EST) -- Members of the Sackler family, which owns OxyContin maker Purdue Pharma LP, discussed potential opioid litigation as a threat to the family's and company's finances as early as 2007, according to filings in New York bankruptcy court.

According to the unsecured creditors committee in the Purdue bankruptcy, dozens of emails and memos show that members of the Sackler family were shaken following the company's 2007 $600 million deal with the government over the marketing of OxyContin. Those documents dispute the Sacklers' claims that no one could have predicted the wave of litigation over the crisis before 2017, and there is also probable cause...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!